Akademska digitalna zbirka SLovenije - logo
E-viri
Celotno besedilo
Recenzirano Odprti dostop
  • The orange-III study: the u...
    van Woerden, V.; Olij, Bram; Fichtinger, Robert S.; Lodewick, Toine M.; Coolsen, Mariëlle M.E.; Den Dulk, Marcel; Heise, Daniel; Olde Damink, Steven W.M.; Dejong, Cornelis H.C.; Neumann, Ulf P.; van Dam, Ronald M.

    HPB (Oxford, England), 09/2022, Letnik: 24, Številka: 9
    Journal Article

    This study evaluates the effect of preoperative macrogol on gastrointestinal recovery and functional recovery after liver surgery combined with an enhanced recovery programme in a randomized controlled setting. Patients were randomized to either 1 sachet of macrogol a day, one week prior to surgery versus no preoperative laxatives. Postoperative management for all patients was within an enhanced recovery programme. The primary outcome was recovery of gastrointestinal function, defined as Time to First Defecation. Secondary outcomes included Time to Functional Recovery. Between August 2012 and September 2016, 82 patients planned for liver resection were included in the study, 39 in the intervention group and 43 in the control group. Median Time to First Defecation was 4.0 days in the intervention group (IQR 2.8–5.0) and 4.0 days in the control group (IQR 2.9–5.0), P = 0.487. Median Time to Functional Recovery was day 6 (IQR 4.0–8.0) in the intervention group and day 5 (IQR 4.0–7.5) in the control group, P = 0.752. No significant differences were seen in complication rate, reinterventions or mortality. This randomized controlled trial showed no advantages of 1 sachet of macrogol preoperatively combined with an enhanced recovery programme, for patients undergoing liver surgery.